Surge in Ceftriaxone-Resistant Neisseria Gonorrhoeae FC428-Like Strains, Asia-Pacific Region, 2015-2022

Overview

Journal Emerg Infect Dis

Specialty Infectious Diseases

Date 2024 Jul 23

PMID 39043453

Authors

Leshan Xiu

Lulu Zhang

Junping Peng

Affiliations

Soon will be listed here.

Abstract

Ceftriaxone-resistant Neisseria gonorrhoeae FC428-like strains have disseminated across the Asia-Pacific region, with a continuous rise in prevalence during 2015-2022. To mitigate the effect of these strains, we advocate for enhanced molecular diagnostics, expanded surveillance networks, and a regionally coordinated effort to combat the global spread of FC428-like strains.

Citing Articles

Multigeographic clinical assessment of a molecular diagnostic assay for detection of key codons to predict decreased susceptibility or resistance to cephalosporins in .

Wang L, Li Y, Xiu L, Hu L, Huang J, Yong G Antimicrob Agents Chemother. 2024; 68(12):e0116524.

PMID: 39470197 PMC: 11620283. DOI: 10.1128/aac.01165-24.

References

Unemo M, Bradshaw C, Hocking J, de Vries H, Francis S, Mabey D . Sexually transmitted infections: challenges ahead. Lancet Infect Dis. 2017; 17(8):e235-e279. DOI: 10.1016/S1473-3099(17)30310-9. View

Yam E, Hsu L, Yap E, Yeo T, Lee V, Schlundt J . Antimicrobial Resistance in the Asia Pacific region: a meeting report. Antimicrob Resist Infect Control. 2020; 8:202. PMC: 6921568. DOI: 10.1186/s13756-019-0654-8. View

Lee K, Nakayama S, Osawa K, Yoshida H, Arakawa S, Furubayashi K . Clonal expansion and spread of the ceftriaxone-resistant Neisseria gonorrhoeae strain FC428, identified in Japan in 2015, and closely related isolates. J Antimicrob Chemother. 2019; 74(7):1812-1819. DOI: 10.1093/jac/dkz129. View

Day M, Pitt R, Mody N, Saunders J, Rai R, Nori A . Detection of 10 cases of ceftriaxone-resistant in the United Kingdom, December 2021 to June 2022. Euro Surveill. 2022; 27(46). PMC: 9673238. DOI: 10.2807/1560-7917.ES.2022.27.46.2200803. View

Sanchez-Buso L, Yeats C, Taylor B, Goater R, Underwood A, Abudahab K . A community-driven resource for genomic epidemiology and antimicrobial resistance prediction of Neisseria gonorrhoeae at Pathogenwatch. Genome Med. 2021; 13(1):61. PMC: 8054416. DOI: 10.1186/s13073-021-00858-2. View

Tickner J, Lahra M, Whiley D . The need for a commercial test using the penA60 allele to identify ceftriaxone-resistant Neisseria gonorrhoeae. Lancet Infect Dis. 2022; 22(9):1271-1272. DOI: 10.1016/S1473-3099(22)00520-5. View

Lahra M, Ryder N, Whiley D . A new multidrug-resistant strain of Neisseria gonorrhoeae in Australia. N Engl J Med. 2014; 371(19):1850-1. DOI: 10.1056/NEJMc1408109. View

Yuan Q, Li Y, Xiu L, Zhang C, Fu Y, Jiang C . Identification of multidrug-resistant isolates with combined resistance to both ceftriaxone and azithromycin, China, 2017-2018. Emerg Microbes Infect. 2019; 8(1):1546-1549. PMC: 6830194. DOI: 10.1080/22221751.2019.1681242. View

Maubaret C, Camelena F, Mrimeche M, Braille A, Liberge M, Mainardis M . Two cases of extensively drug-resistant (XDR) infection combining ceftriaxone-resistance and high-level azithromycin resistance, France, November 2022 and May 2023. Euro Surveill. 2023; 28(37). PMC: 10687985. DOI: 10.2807/1560-7917.ES.2023.28.37.2300456. View

10.

Xiu L, Wang L, Li Y, Hu L, Huang J, Yong G . Multicentre Clinical Evaluation of a Molecular Diagnostic Assay to Identify Neisseria gonorrhoeae Infection and Detect Antimicrobial Resistance. Int J Antimicrob Agents. 2023; 61(5):106785. DOI: 10.1016/j.ijantimicag.2023.106785. View

11.

Ouk V, Pham C, Wi T, van Hal S, Lahra M . The Enhanced Gonococcal Surveillance Programme, Cambodia. Lancet Infect Dis. 2023; 23(9):e332-e333. DOI: 10.1016/S1473-3099(23)00479-6. View

12.

Golparian D, Unemo M . Now Is the Time to Implement Whole Genome Sequencing in the Global Antimicrobial Resistance Surveillance for ?. EClinicalMedicine. 2019; 7:11-12. PMC: 6539334. DOI: 10.1016/j.eclinm.2019.02.002. View

13.

Unemo M, Lahra M, Escher M, Eremin S, Cole M, Galarza P . WHO global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017-18: a retrospective observational study. Lancet Microbe. 2022; 2(11):e627-e636. DOI: 10.1016/S2666-5247(21)00171-3. View